Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

QuatRx Pharmaceuticals

QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. We currently have three product candidates in clinical development and one compound that we expect to enter clinical development in 2006. Our two lead compounds, Ophena™ and fispemifene, treat hormone deficiencies that result from aging in men and women.

Ophena™ (ospemifene), our treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women, has entered Phase III clinical testing.


Contact Details:
777 East Eisenhower Parkway, Suite 100
Ann Arbor
Michigan
48108
United States of America
Tel:(734) 913-9900
Fax:(734) 913-0743
Email:info@QuatRx.com
WWW:

www.quatrx.com/




Loading...

Press Releases on QuatRx Pharmaceuticals:

BioPortfolio Logo
QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 31st March, 2009 QuatRx Pharmaceuticals
ANN ARBOR, Mich., March 31 /PRNewswire/ -- QuatRx Pharmaceuticals, a privately-held biopharmaceutical company, today announced that it has completed enrollment in the Company's second pivotal
QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 4th September, 2008 QuatRx Pharmaceuticals
ANN ARBOR, Mich., Sept. 4 /PRNewswire/ -- QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic

BioNews Results for QuatRx Pharmaceuticals:

PharmaVigilant Demystifies Clinical Trial Process Costs and Improves Access to Data by Offering Sponsors Compl
Genetic Engineering News:  Nov 3 2009 2:18PM Matching: quatrx pharmaceuticals
Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Miles
Pharmacy Choice:  Oct 21 2009 9:22AM Matching: quatrx pharmaceuticals
Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones
FinanzNachrichten.de:  Oct 20 2009 6:59PM Matching: quatrx pharmaceuticals
Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Milestones
FinanzNachrichten.de:  Oct 20 2009 6:58PM Matching: quatrx pharmaceuticals
Hercules Technology Growth Capital Announces Three Portfolio Companies That Reached Multi-Million Dollar Miles
Street Insider:  Oct 20 2009 7:11PM Matching: quatrx pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more QuatRx Pharmaceuticals news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 242 times since April 2007, the link to the organisation's website has been followed 46 times

Search for more companies in Ann Arbor

Search for more companies in Michigan



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for QuatRx Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.